Clinical trials
Completed Overweight trials in Japan
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
22 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2013 | 1 |
| 2018 | 3 |
| 2019 | 3 |
| 2021 | 3 |
| 2023 | 6 |
| 2024 | 4 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 22 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novo Nordisk A/S | 10 |
| Eli Lilly and Company | 5 |
| AstraZeneca | 4 |
| Amgen | 1 |
| Hiroshima University | 1 |
| Sapporo Health Promotion Foundation | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Overweight | 22 |
| Obesity | 20 |
| Nutrition Disorders | 4 |
| Diabetes Mellitus, Type 2 | 3 |
| Diabetes Mellitus | 1 |
| Hyperlipidemias | 1 |
| Hypertension | 1 |
| Metabolic Diseases | 1 |
| Prediabetic State | 1 |
Trials
Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.